Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Optimized Solubilization of Albizia myriophylla Benth. Extract Using I-Optimal Design for Anti-Streptococcus mutans Activity.

Created on 24 Jul 2026

Authors

Chaowalit Monton, Thaniya Wunnakup, Jirapornchai Suksaeree

Published in

Scientifica. Volume 2026. Pages 3315055. Epub Jul 23, 2026.

Abstract

Albizia myriophylla Benth. is a medicinal plant possessing anti-Streptococcus mutans activity, a key pathogen associated with dental caries, due to the presence of antimicrobial compounds such as lupinifolin. This study aimed to optimize a solvent system for solubilizing A. myriophylla extract. Initially, the anti-S. mutans activity of the stem extract was determined, revealing minimum inhibitory and minimum bactericidal concentrations of 8 and 256 μg/mL, respectively. Five solvents-water, 95% ethanol, glycerin, polyethylene glycol (PEG) 400, and propylene glycol (PG)-were evaluated. The extract exhibited higher solubility in PG, followed by 95% ethanol and PEG 400. Based on these results, 95% ethanol, PG, and water were selected for mixture optimization using an I-optimal design. A design space was constructed to ensure a minimum of 90% recovery of lupinifolin, achieving approximately 50% of the defined knowledge space. The optimal formulation for preparing a 5% A. myriophylla extract consisted of 95% ethanol, PG, and water in a mass ratio of 0.30:0.63:0.07. This formulation yielded a lupinifolin recovery ranging from 94.18% to 101.01%. A verification step confirmed the predictive accuracy and reliability of the model. Finally, the optimal formulation was evaluated for its anti-S. mutans activity, which demonstrated effective antimicrobial properties. In conclusion, this study successfully identified a suitable solvent system for solubilizing A. myriophylla extract, which can serve as a guideline for the development of oral sprays targeting S. mutans in future research.

PMID:
42495598
Bibliographic data and abstract were imported from PubMed on 24 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement